IRX Therapeutics' Series E Round

IRX Therapeutics raised a round of funding on January 12, 2017.

IRX Therapeutics develops immune therapies to treat cancer and related diseases. The company's therapies are designed to target and restore the immune system in order to improve a patient's response t…

Articles about IRX Therapeutics' Series E Round: